-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO PHARMA - TO SUBMIT MAA FOR ACHONDROPLASIA TO EMA IN Q4 2026

路透·10/06/2026 11:30:01

请登录查看新闻详情